In brief: Multiple Sclerosis Society

The Multiple Sclerosis Society has condemned as 'breathtaking bungling' the announcement by the National Institute for Clinical Excellence that no decision on the drugs beta interferon and glatiramer acetate will be made before July 2001. NICE said new evidence had come to light which needed to be taken into account.

You need to be a subscriber to read more

HSJ

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All HSJ news by sector, topic & region
  • Breaking News announcements
  • App for mobile and offline reading
  • Comment and Daily Insights newsletters
  • Regional roundup newsletters
  • 10 expert briefings every fortnight (Premium only)
  • Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)

Already a subscriber? Sign into your account here